Literature DB >> 7688473

Nitric oxide activates cyclooxygenase enzymes.

D Salvemini1, T P Misko, J L Masferrer, K Seibert, M G Currie, P Needleman.   

Abstract

We have evaluated the role of nitric oxide (NO) on the activity of the constitutive and induced forms of cyclooxygenase (COX; COX-1 and COX-2, respectively). Induction of NO synthase (NOS) and COX (COX-2) in the mouse macrophage cell line RAW264.7 by Escherichia coli lipopolysaccharide (1 microgram/ml, 18 h) caused an increase in the release of nitrite (NO2-) and prostaglandin E2 (PGE2), products of NOS and COX, respectively. Production of both NO2- and PGE2 was blocked by the NOS inhibitors NG-monomethyl-L-arginine or aminoguanidine. The effects of NG-monomethyl-L-arginine or aminoguanidine were reversed by coincubation with L-Arg, the precursor for NO synthesis, but not by D-Arg. RAW264.7 cells stimulated for 18 h with lipopolysaccharide in L-Arg-free medium (to reduce NO generation by the endogenous NOS pathway) failed to release NO2- and accumulated at least 4-fold less PGE2 when compared to cells in the presence of L-Arg. PGE2 production elicited by a 15-min arachidonic acid treatment of lipopolysaccharide-induced RAW264.7 cells in L-Arg-deficient medium was decreased 3-fold when compared to the release obtained with cells induced in medium containing L-Arg. To examine the NO activation of the induced form of COX in the absence of an endogenous L-Arg, human fetal fibroblasts were first stimulated for 18 h with interleukin 1 beta. These cells released PGE2 but not NO2-, consistent with the induction of COX but not NOS in the fibroblast. Exogenous NO either as a gaseous solution or released by a NO donor, sodium nitroprusside or glyceryl trinitrate, increased COX activity in the interleukin 1 beta-stimulated fibroblasts by 5-fold; these effects were abolished by coincubation with hemoglobin (10 microM), which binds and inactivates NO, but not by methylene blue, an inhibitor of the soluble guanylate cyclase. Furthermore, sodium nitroprusside (0.25-1 mM) increased arachidonic acid-stimulated PGE2 production by murine recombinant COX-1 and COX-2. These results demonstrate that NO enhances COX activity through a mechanism independent of cGMP and suggest that, in conditions in which both the NOS and COX systems are present, there is an NO-mediated increase in the production of proinflammatory prostaglandins that may result in an exacerbated inflammatory response. The data suggest that NO directly interacts with COX to cause an increase in the enzymatic activity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7688473      PMCID: PMC47112          DOI: 10.1073/pnas.90.15.7240

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

Review 1.  Nitric oxide: physiology, pathophysiology, and pharmacology.

Authors:  S Moncada; R M Palmer; E A Higgs
Journal:  Pharmacol Rev       Date:  1991-06       Impact factor: 25.468

Review 2.  Prostaglandin endoperoxide synthase: regulation of enzyme expression.

Authors:  D L DeWitt
Journal:  Biochim Biophys Acta       Date:  1991-05-08

3.  Endogenous glucocorticoids regulate an inducible cyclooxygenase enzyme.

Authors:  J L Masferrer; K Seibert; B Zweifel; P Needleman
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

4.  Nitric oxide, an inhibitor of lipid oxidation by lipoxygenase, cyclooxygenase and hemoglobin.

Authors:  J Kanner; S Harel; R Granit
Journal:  Lipids       Date:  1992-01       Impact factor: 1.880

5.  Effect of vasodilators, including nitric oxide, on the release of cGMP and cAMP in the isolated perfused rat kidney.

Authors:  I Heuzé-Joubert; P Mennecier; S Simonet; M Laubie; T J Verbeuren
Journal:  Eur J Pharmacol       Date:  1992-09-22       Impact factor: 4.432

Review 6.  Nitric oxide as a secretory product of mammalian cells.

Authors:  C Nathan
Journal:  FASEB J       Date:  1992-09       Impact factor: 5.191

7.  Endotoxin-induced vasodilatation in anaesthetized rat skin involves nitric oxide and prostaglandin synthesis.

Authors:  J B Warren; M L Coughlan; T J Williams
Journal:  Br J Pharmacol       Date:  1992-08       Impact factor: 8.739

8.  Nitric oxide mediates norepinephrine-induced prostaglandin E2 release from the hypothalamus.

Authors:  V Rettori; M Gimeno; K Lyson; S M McCann
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-01       Impact factor: 11.205

9.  Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction.

Authors:  J A Corbett; R G Tilton; K Chang; K S Hasan; Y Ido; J L Wang; M A Sweetland; J R Lancaster; J R Williamson; M L McDaniel
Journal:  Diabetes       Date:  1992-04       Impact factor: 9.461

10.  The metabolism of glyceryl trinitrate to nitric oxide in the macrophage cell line J774 and its induction by Escherichia coli lipopolysaccharide.

Authors:  D Salvemini; A Pistelli; V Mollace; E Anggård; J Vane
Journal:  Biochem Pharmacol       Date:  1992-07-07       Impact factor: 5.858

View more
  231 in total

1.  Role of nitric oxide in the induction of apoptosis by smokeless tobacco extract.

Authors:  R S Mangipudy; J K Vishwanatha
Journal:  Mol Cell Biochem       Date:  1999-10       Impact factor: 3.396

Review 2.  Nitric oxide and its role in blastocyst implantation.

Authors:  Omid Khorram
Journal:  Rev Endocr Metab Disord       Date:  2002-05       Impact factor: 6.514

3.  Modulation of nitric oxide synthase activity by ibuprofen.

Authors:  J E Menzel; G Kolarz
Journal:  Inflammation       Date:  1997-08       Impact factor: 4.092

4.  Basal nitric oxide production is enhanced by hydraulic pressure in cultured human trabecular cells.

Authors:  T Matsuo
Journal:  Br J Ophthalmol       Date:  2000-06       Impact factor: 4.638

Review 5.  Roles of reactive oxygen and nitrogen species in pain.

Authors:  Daniela Salvemini; Joshua W Little; Timothy Doyle; William L Neumann
Journal:  Free Radic Biol Med       Date:  2011-01-28       Impact factor: 7.376

6.  COX-2 contributes to the maintenance of flow-induced dilation in arterioles of eNOS-knockout mice.

Authors:  Dong Sun; Hong Liu; Changdong Yan; Azita Jacobson; Caroline Ojaimi; An Huang; Gabor Kaley
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-04-21       Impact factor: 4.733

Review 7.  On the selectivity of superoxide dismutase mimetics and its importance in pharmacological studies.

Authors:  Carolina Muscoli; Salvatore Cuzzocrea; Dennis P Riley; Jay L Zweier; Christoph Thiemermann; Zhi-Qiang Wang; Daniela Salvemini
Journal:  Br J Pharmacol       Date:  2003-10       Impact factor: 8.739

8.  Early aseptic loosening of cemented total hip arthroplasty: the influence of non-steroidal anti-inflammatory drugs and smoking.

Authors:  M H A Malik; J Gray; P R Kay
Journal:  Int Orthop       Date:  2004-03-27       Impact factor: 3.075

Review 9.  Reciprocal regulation of the nitric oxide and cyclooxygenase pathway in pathophysiology: relevance and clinical implications.

Authors:  Daniela Salvemini; Sangwon F Kim; Vincenzo Mollace
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-02-06       Impact factor: 3.619

Review 10.  Discovery of a new function of cyclooxygenase (COX)-2: COX-2 is a cardioprotective protein that alleviates ischemia/reperfusion injury and mediates the late phase of preconditioning.

Authors:  Roberto Bolli; Ken Shinmura; Xian-Liang Tang; Eitaro Kodani; Yu-Ting Xuan; Yiru Guo; Buddhadeb Dawn
Journal:  Cardiovasc Res       Date:  2002-08-15       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.